227 Meta-analysis female sex and mortality in SAB 10 16. Hartung J, Knapp G. On tests of the overall treatment effect in meta-analysis with normally distributed responses. Stat Med. 2001;20(12):1771-1782. 17. Hartung J, Knapp G. A refined method for the meta-analysis of controlled clinical trials with binary outcome. Stat Med. 2001;20(24):3875-3889. 18. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634. 19. Berkman ND, Lohr KN, Ansari MT, et al. Grading the strength of a body of evidence when assessing health care interventions: an EPC update. J Clin Epidemiol. 2015;68(11):13121324. 20. Abbas M, Rossel A, de Kraker MEA, et al. Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study. Clin Microbiol Infect. 2020;26(5):626-631. 21. Allard C, Carignan A, Bergevin M, et al. Secular changes in incidence and mortality associated with Staphylococcus aureus bacteraemia in Quebec, Canada, 1991-2005. Clin Microbiol Infect. 2008;14(5):421-428. 22. Ammerlaan H, Seifert H, Harbarth S, et al; European Practices of Infections with Staphylococcus aureus (SEPIA) Study Group. Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries. Clin Infect Dis. 2009;49(7):997-1005. 23. Asgeirsson H, Gudlaugsson O, Kristinsson KG, Heiddal S, Kristjansson M. Staphylococcus aureus bacteraemia in Iceland, 1995-2008: changing incidence and mortality. Clin Microbiol Infect. 2011;17(4):513-518. 24. Ayau P, Bardossy AC, Sanchez G, et al. Risk factors for 30-day mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infections. Int J Infect Dis. 2017;61:3-6. 25. Bai AD, Showler A, Burry L, et al. Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study. J Antimicrob Chemother. 2015;70(5):1539-1546. 26. Bassetti M, Peghin M, Trecarichi EM, et al. Characteristics of Staphylococcus aureus bacteraemia and predictors of early and late mortality. PLoS One. 2017;12(2):e0170236. 27. Battle SE, Shuping M, Withers S, Justo JA, Bookstaver PB, Al-Hasan MN. Prediction of mortality in Staphylococcus aureus bloodstream infection using quick Pitt bacteremia score. J Infect. 2022;84(2):131-135. 28. Ben-Zvi H, Drozdinsky G, Kushnir S, et al. Influence of GeneXpert MRSA/SA test implementation on clinical outcomes of Staphylococcus aureus bacteremia—a beforeafter retrospective study. Diagn Microbiol Infect Dis. 2019;93(2):120-124. 29. Benfield T, Espersen F, Frimodt-Møller N, et al. Increasing incidence but decreasing inhospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect. 2007;13(3):257-263. 30. Blomfeldt A, Eskesen AN, Aamot HV, Leegaard TM, Bjørnholt JV. Population-based epidemiology of Staphylococcus aureus bloodstream infection: clonal complex 30 genotype is associated with mortality. Eur J Clin Microbiol Infect Dis. 2016;35(5):803-813. 31. Braquet P, Alla F, Cornu C, et al; VIRSTA-AEPEI study group. Factors associated with 12 week case-fatality in Staphylococcus aureus bacteraemia: a prospective cohort study. Clin Microbiol Infect. 2016;22(11):948.e1-948.e7.
RkJQdWJsaXNoZXIy MTk4NDMw